-
1
-
-
0036097509
-
Outcome predictions for patients with metastatic prostate cancer
-
Smaletz O, Scher HI. Outcome predictions for patients with metastatic prostate cancer. Semin Urol Oncol 2002;20:155-63.
-
(2002)
Semin. Urol. Oncol.
, vol.20
, pp. 155-163
-
-
Smaletz, O.1
Scher, H.I.2
-
2
-
-
0141956345
-
Intermittent chemotherapy in metastatic androgen-independent prostate cancer
-
Beer TM, Garzotto M, Henner WD, Eilers KM, Wersinger EM. Intermittent chemotherapy in metastatic androgen-independent prostate cancer. Br J Cancer 2003;89:968-70.
-
(2003)
Br. J. Cancer
, vol.89
, pp. 968-970
-
-
Beer, T.M.1
Garzotto, M.2
Henner, W.D.3
Eilers, K.M.4
Wersinger, E.M.5
-
3
-
-
0242407666
-
Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: Results of a Minnie Pearl Cancer Research Network phase II trial
-
Meluch AA, Greco FA, Morrissey LH, et al. Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial. Cancer 2003;98:2192-8.
-
(2003)
Cancer
, vol.98
, pp. 2192-2198
-
-
Meluch, A.A.1
Greco, F.A.2
Morrissey, L.H.3
-
4
-
-
0036671675
-
Chemotherapy for androgen-independent prostate cancer
-
Petrylak DP. Chemotherapy for androgen-independent prostate cancer. Semin Urol Oncol 2002;20:31-5.
-
(2002)
Semin. Urol. Oncol.
, vol.20
, pp. 31-35
-
-
Petrylak, D.P.1
-
5
-
-
12244302200
-
Role of chemotherapy in hormone-refractory prostate cancer. Old issues, recent advances and new perspectives
-
Autorino R, Di Lorenzo G, Damiano R, De Placido S, D'Armiento M. Role of chemotherapy in hormone-refractory prostate cancer. Old issues, recent advances and new perspectives. Urol Int 2003;70:1-14.
-
(2003)
Urol. Int.
, vol.70
, pp. 1-14
-
-
Autorino, R.1
Di Lorenzo, G.2
Damiano, R.3
De Placido, S.4
D'Armiento, M.5
-
6
-
-
0025027766
-
Antitumor activity of Adriamycin (hydrazone-linked) immunoconjugates compared with free Adriamycin and specificity of tumor cell killing
-
Braslawsky GR, Edson MA, Pearce W, Kaneko T, Greenfield RS. Antitumor activity of Adriamycin (hydrazone-linked) immunoconjugates compared with free Adriamycin and specificity of tumor cell killing. Cancer Res 1990;50:6608-14.
-
(1990)
Cancer Res.
, vol.50
, pp. 6608-6614
-
-
Braslawsky, G.R.1
Edson, M.A.2
Pearce, W.3
Kaneko, T.4
Greenfield, R.S.5
-
7
-
-
0034050268
-
Monoclonal antibodies to the myeloid stem cells: Therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate
-
Bernstein ID. Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate. Leukemia 2000;14:474-5.
-
(2000)
Leukemia
, vol.14
, pp. 474-475
-
-
Bernstein, I.D.1
-
8
-
-
0141919559
-
E-selectin up-regulation allows for targeted drug delivery in prostate cancer
-
Bhaskar V, Law DA, Ibsen E, et al. E-selectin up-regulation allows for targeted drug delivery in prostate cancer. Cancer Res 2003;63: 6387-94.
-
(2003)
Cancer Res.
, vol.63
, pp. 6387-6394
-
-
Bhaskar, V.1
Law, D.A.2
Ibsen, E.3
-
9
-
-
10744222473
-
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
-
Doronina SO, Toki BE, Torgov MY, et al. Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nat Biotechnol 2003;21:778-84.
-
(2003)
Nat. Biotechnol.
, vol.21
, pp. 778-784
-
-
Doronina, S.O.1
Toki, B.E.2
Torgov, M.Y.3
-
10
-
-
0042738861
-
cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity
-
Francisco JA, Cerveny CG, Meyer DL, et al. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood 2003;102:1458-65.
-
(2003)
Blood
, vol.102
, pp. 1458-1465
-
-
Francisco, J.A.1
Cerveny, C.G.2
Meyer, D.L.3
-
11
-
-
9444235053
-
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids
-
Liu C, Tadayoni BM, Bourret LA, et al. Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. Proc Natl Acad Sci USA 1996;93:8618-23.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 8618-8623
-
-
Liu, C.1
Tadayoni, B.M.2
Bourret, L.A.3
-
12
-
-
0036569591
-
Prostate stem cell antigen as therapy target: Tissue expression and in vivo efficacy of an immunoconjugate
-
Ross S, Spencer SD, Holcomb I, et al. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res 2002;62:2546-53.
-
(2002)
Cancer Res.
, vol.62
, pp. 2546-2553
-
-
Ross, S.1
Spencer, S.D.2
Holcomb, I.3
-
13
-
-
0037440038
-
Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: A phase I, pharmacokinetic, and biologic correlative study
-
Tolcher AW, Ochoa L, Hammond LA, et al. Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study. J Clin Oncol 2003;21:211-22.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 211-222
-
-
Tolcher, A.W.1
Ochoa, L.2
Hammond, L.A.3
-
14
-
-
0142030952
-
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen
-
Bander NH, Nanus DM, Milowsky MI, Kostakoglu L, Vallabahajosula S, Goldsmith SJ. Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen. Semin Oncol 2003;30:667-76.
-
(2003)
Semin. Oncol.
, vol.30
, pp. 667-676
-
-
Bander, N.H.1
Nanus, D.M.2
Milowsky, M.I.3
Kostakoglu, L.4
Vallabahajosula, S.5
Goldsmith, S.J.6
-
15
-
-
0033589283
-
Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays
-
Bubendorf L, Kolmer M, Kononen J, et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 1999;91:1758-64.
-
(1999)
J. Natl. Cancer Inst.
, vol.91
, pp. 1758-1764
-
-
Bubendorf, L.1
Kolmer, M.2
Kononen, J.3
-
16
-
-
0035874995
-
Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling
-
Luo J, Duggan DJ, Chen Y, et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 2001;61:4683-8.
-
(2001)
Cancer Res.
, vol.61
, pp. 4683-4688
-
-
Luo, J.1
Duggan, D.J.2
Chen, Y.3
-
17
-
-
0035881732
-
Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer
-
Welsh JB, Sapinoso LM, Su AI, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001;61:5974-8.
-
(2001)
Cancer Res.
, vol.61
, pp. 5974-5978
-
-
Welsh, J.B.1
Sapinoso, L.M.2
Su, A.I.3
-
18
-
-
0347357903
-
Looking beyond morphology: Cancer gene expression profiling using DNA microarrays
-
Luo J, Isaacs WB, Trent JM, Duggan DJ. Looking beyond morphology: cancer gene expression profiling using DNA microarrays. Cancer Invest 2003;21:937-49.
-
(2003)
Cancer Invest.
, vol.21
, pp. 937-949
-
-
Luo, J.1
Isaacs, W.B.2
Trent, J.M.3
Duggan, D.J.4
-
19
-
-
0141506941
-
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer
-
Henshall SM, Afar DE, Rasiah KK, et al. Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer. Oncogene 2003;22:6005-12.
-
(2003)
Oncogene
, vol.22
, pp. 6005-6012
-
-
Henshall, S.M.1
Afar, D.E.2
Rasiah, K.K.3
-
20
-
-
18144435003
-
Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons
-
Horie M, Mitsumoto Y, Kyushiki H, et al. Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons. Genomics 2000;67:146-52.
-
(2000)
Genomics
, vol.67
, pp. 146-152
-
-
Horie, M.1
Mitsumoto, Y.2
Kyushiki, H.3
-
21
-
-
0033590080
-
A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells
-
Uchida T, Wada K, Akamatsu T, et al. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem Biophys Res Commun 1999;266:593-602.
-
(1999)
Biochem. Biophys. Res. Commun.
, vol.266
, pp. 593-602
-
-
Uchida, T.1
Wada, K.2
Akamatsu, T.3
-
22
-
-
0034282986
-
The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells
-
Liang G, Robertson KD, Talmadge C, Sumegi J, Jones PA. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Cancer Res 2000;60:4907-12.
-
(2000)
Cancer Res.
, vol.60
, pp. 4907-4912
-
-
Liang, G.1
Robertson, K.D.2
Talmadge, C.3
Sumegi, J.4
Jones, P.A.5
-
23
-
-
0035888159
-
TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence
-
Glynne-Jones E, Harper ME, Seery LT, et al. TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. Int J Cancer 2001;94:178-84.
-
(2001)
Int. J. Cancer
, vol.94
, pp. 178-184
-
-
Glynne-Jones, E.1
Harper, M.E.2
Seery, L.T.3
-
24
-
-
0042674136
-
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse
-
Henshall SM, Afar DE, Hiller J, et al. Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res 2003;63:4196-203.
-
(2003)
Cancer Res.
, vol.63
, pp. 4196-4203
-
-
Henshall, S.M.1
Afar, D.E.2
Hiller, J.3
-
25
-
-
0004032583
-
Sequences of proteins of immunological interest
-
5th ed. Washington (DC): U.S. Department of Health and Human Services, NIH
-
Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of proteins of immunological interest. 5th ed. Washington (DC): U.S. Department of Health and Human Services, NIH; 1991.
-
(1991)
-
-
Kabat, E.A.1
Wu, T.T.2
Perry, H.M.3
Gottesman, K.S.4
Foeller, C.5
-
27
-
-
0032694334
-
Immunoglobulin VH gene expression in human aging
-
Wang X, Stollar BD. Immunoglobulin VH gene expression in human aging. Clin Immunol 1999;93:132-42.
-
(1999)
Clin. Immunol.
, vol.93
, pp. 132-142
-
-
Wang, X.1
Stollar, B.D.2
-
28
-
-
0034650994
-
Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes
-
van Den Brink EN, Turenhout EA, Davies J, et al. Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes. Blood 2000;95:558-63.
-
(2000)
Blood
, vol.95
, pp. 558-563
-
-
van Den Brink, E.N.1
Turenhout, E.A.2
Davies, J.3
-
29
-
-
0028784138
-
Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides
-
Stemmer WP, Crameri A, Ha KD, Brennan TM, Heyneker HL. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 1995;164:49-53.
-
(1995)
Gene
, vol.164
, pp. 49-53
-
-
Stemmer, W.P.1
Crameri, A.2
Ha, K.D.3
Brennan, T.M.4
Heyneker, H.L.5
-
30
-
-
0031822837
-
Tissue microarrays for high-throughput molecular profiling of tumor specimens
-
Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4:844-7.
-
(1998)
Nat. Med.
, vol.4
, pp. 844-847
-
-
Kononen, J.1
Bubendorf, L.2
Kallioniemi, A.3
-
33
-
-
0035101380
-
The control of prostate-specific antigen expression and gene regulation by pharmacological agents
-
Dixon SC, Knopf KB, Figg WD. The control of prostate-specific antigen expression and gene regulation by pharmacological agents. Pharmacol Rev 2001;53:73-91.
-
(2001)
Pharmacol. Rev.
, vol.53
, pp. 73-91
-
-
Dixon, S.C.1
Knopf, K.B.2
Figg, W.D.3
-
34
-
-
0035793108
-
HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers
-
Young J, Biden KG, Simms LA, et al. HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci USA 2001;98:265-70.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 265-270
-
-
Young, J.1
Biden, K.G.2
Simms, L.A.3
-
35
-
-
0037130470
-
TMEFF2 is an androgen-regulated gene exhibiting anti proliferative effects in prostate cancer cells
-
Gary S, Sawyers CL, Agus DB, Said JW, Koeffler HP. TMEFF2 is an androgen-regulated gene exhibiting anti proliferative effects in prostate cancer cells. Oncogene 2002;21:4739-46.
-
(2002)
Oncogene
, vol.21
, pp. 4739-4746
-
-
Gary, S.1
Sawyers, C.L.2
Agus, D.B.3
Said, J.W.4
Koeffler, H.P.5
-
36
-
-
0036604401
-
Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer
-
Mohler JL, Morris TL, Ford OH III, Alvey RF, Sakamoto C, Gregory CW. Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate 2002;51: 247-55.
-
(2002)
Prostate
, vol.51
, pp. 247-255
-
-
Mohler, J.L.1
Morris, T.L.2
Ford III, O.H.3
Alvey, R.F.4
Sakamoto, C.5
Gregory, C.W.6
-
37
-
-
0026418194
-
Humanized antibodies for therapy
-
Co MS, Queen C. Humanized antibodies for therapy. Nature 1991; 351:501-2.
-
(1991)
Nature
, vol.351
, pp. 501-502
-
-
Co, M.S.1
Queen, C.2
-
38
-
-
0029063667
-
Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2
-
Hooijberg E, Sein JJ, van den Berk PC, et al. Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2. Cancer Res 1995;55:2627-34.
-
(1995)
Cancer Res.
, vol.55
, pp. 2627-2634
-
-
Hooijberg, E.1
Sein, J.J.2
van den Berk, P.C.3
-
39
-
-
0031031895
-
Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates
-
Trail PA, Willner D, Knipe J, et al. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. Cancer Res 1997;57:100-5.
-
(1997)
Cancer Res.
, vol.57
, pp. 100-105
-
-
Trail, P.A.1
Willner, D.2
Knipe, J.3
-
40
-
-
0742287749
-
Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): Studies in nude mice
-
Vallabhajosula S, Smith-Jones PM, Navarro V, Goldsmith SJ, Bander NH. Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude mice. Prostate 2004;58:145-55.
-
(2004)
Prostate
, vol.58
, pp. 145-155
-
-
Vallabhajosula, S.1
Smith-Jones, P.M.2
Navarro, V.3
Goldsmith, S.J.4
Bander, N.H.5
-
41
-
-
0035977710
-
Expression of TMEFF1 mRNA in the mouse central nervous system: Precise examination and comparative studies of TMEFF1 and TMEFF2
-
Kanemoto N, Horie M, Omori K, et al. Expression of TMEFF1 mRNA in the mouse central nervous system: precise examination and comparative studies of TMEFF1 and TMEFF2. Brain Res Mol Brain Res 2001;86: 48-55.
-
(2001)
Brain Res. Mol. Brain Res.
, vol.86
, pp. 48-55
-
-
Kanemoto, N.1
Horie, M.2
Omori, K.3
|